| Short Description : | Recombinant-SARS-CoV-2 Spike S1 (B.1.1.529/Omicron)-C-His protein was developed in hek293 cells using the region Gln14-Arg683. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 1 EU/Mu g of the protein by LAL method. |
| Immunogen: | Recombinant SARS-CoV-2 Spike S1 (B.1.1.529/Omicron) Protein is produced by Expi293 cells expression system. The target protein is expressed with sequence (Gln14-Arg683 (A67V, HV69-70del, T95I, G142D, VYY143-145del, N211del, L212I, ins214EPE, G339D, S |
| Immunogen Region: | Gln14-Arg683 |
| Immunogen Sequence: | Gln14-Arg683 (A67V, H V69-70del, T95I, G14 2D, VYY143-145del, N 211del, L212I, ins21 4EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493 R, G496S, Q498R, N50 1Y, Y505H, T547K, D6 14G, H655Y, N679K, P 681H) |
| Background | The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates thisinteraction.The S protein plays key parts in the induction of neutralizing-antibody and T-cellresponses, as well as protective immunity. |
Information sourced from Uniprot.org
